HMO (Human Milk Oligosaccharides)

HMO Series

BioSync™ 3rd-Gen Precision Yeast Synthesis · Endotoxin-Free

Product Overview

Morika Bio's HMO series is produced via food-grade yeast fermentation to eliminate endotoxin risks inherent in legacy E. coli-based systems. Our platform supports consistent, scalable supply with full technical documentation for global markets.

Key Variants (Typical)

2'-FL

Core HMO for infant nutrition

LNnT

Bifidogenic support

LNTr II

First FDA GRAS globally (platform milestone)

3'-SL

Next-gen HMO extension

Ready to start?

Contact our technical team to discuss specifications, samples, and regulatory documentation.